Successful treatment of a bullous vasculitis with intravenous immunoglobulins in a COVID‐19 patient
Open Access
- 6 February 2021
- journal article
- letter
- Published by Hindawi Limited in Dermatologic Therapy
- Vol. 34 (2), e14853
- https://doi.org/10.1111/dth.14853
Abstract
Click on the article title to read more.Keywords
This publication has 13 references indexed in Scilit:
- Classification of the cutaneous manifestations of COVID ‐19: a rapid prospective nationwide consensus study in Spain with 375 casesBritish Journal of Dermatology, 2020
- Cutaneous signs in COVID ‐19 patients: A reviewDermatologic Therapy, 2020
- Mucous membrane pemphigoid and COVID-19 treated with high-dose intravenous immunoglobulins: a case reportJournal of Dermatological Treatment, 2020
- Coagulopathy and Antiphospholipid Antibodies in Patients with Covid-19The New England Journal of Medicine, 2020
- Endothelial cell infection and endotheliitis in COVID-19The Lancet, 2020
- Acute Hemorrhagic Edema of Infancy after Coronavirus Infection with Recurrent RashCase Reports in Pediatrics, 2017
- Clinical Course and Outcomes of Critically Ill Patients With Middle East Respiratory Syndrome Coronavirus InfectionAnnals of Internal Medicine, 2014
- Cutaneous lesions associated with coronavirus-induced vasculitis in a cat with feline infectious peritonitis and concurrent feline immunodeficiency virus infectionJournal of Feline Medicine and Surgery, 2005
- Autoantibodies against human epithelial cells and endothelial cells after severe acute respiratory syndrome (SARS)‐associated coronavirus infectionJournal of Medical Virology, 2005
- Clinical Manifestations, Laboratory Findings, and Treatment Outcomes of SARS PatientsEmerging Infectious Diseases, 2004